Is Orgenesis Inc. (ORGS) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2023
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 754.2% / 30% | 27.9% / 30% | 85.5% / 30% | 1392.45% / 5% | ✗ NOT HALAL |
| DJIM | 754.2% / 33% | 27.9% / 33% | 85.5% / 33% | 1392.45% / 5% | ✗ NOT HALAL |
| MSCI | 155.4% / 33% | 5.8% / 33% | 17.6% / 33% | 1392.45% / 5% | ✗ NOT HALAL |
| S&P | 754.2% / 33% | 27.9% / 33% | 85.5% / 33% | 1392.45% / 5% | ✗ NOT HALAL |
| FTSE | 155.4% / 33% | 5.8% / 33% | 17.6% / 50% | 1392.45% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | -2196.3% | |
| Net Margin | 0.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$15M |
| Free Cash Flow | -$17M |
| Total Debt | $23M |
| Total Assets | $15M |
Price & Trading
| Last Close | $0.58 |
| 50-Day MA | $0.42 |
| 200-Day MA | $0.57 |
| Avg Volume | 932 |
|
52-Week Range
$0.02
| |
About Orgenesis Inc. (ORGS)
Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare model, POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. It also provides hospital services and cell process development services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Orgenesis Inc. (ORGS) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Orgenesis Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Orgenesis Inc.'s debt ratio?
Orgenesis Inc.'s debt ratio is 754.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 155.4%.
What are Orgenesis Inc.'s key financial metrics?
Orgenesis Inc. has a market capitalization of $3M, and revenue of $530,000.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.